{content}

Study list

COCOPREV

France
|
2021-2022
  • Adults
  • Elderly
  • Fragile population
  • Immunocompromised host
  • Hospital wide
  • Outpatient clinic
  • SARS-CoV-2
  • Acute SARS-CoV-2
  • Pharmacological intervention
  • Monoclonal antibodies
  • Sotrovimab
  • Tixagevimab/Cilgavimab
  • Casirivimab/Imdevimab

Dierckx

Belgium
|
2021-2022
  • Adults
  • General population
  • Elderly
  • Outpatient clinic
  • SARS-CoV-2
  • Post-COVID-19

Vicente-Valor

Spain
|
2021-2022
  • Adults
  • Elderly
  • Fragile population
  • Immunocompromised host
  • Hospital wide
  • SARS-CoV-2
  • Acute SARS-CoV-2
  • Pharmacological intervention
  • Antivirals
  • Remdesivir

LC-cohort

Finland
|
2021-2024
  • Adults
  • Elderly
  • Paediatric
  • Outpatient clinic
  • SARS-CoV-2
  • Post-COVID-19

LCV

Italy
|
2021-2022
  • Adults
  • General population
  • Elderly
  • Community
  • SARS-CoV-2
  • Post-COVID-19

Huygens

The Netherlands
|
2021-2022
  • Adults
  • Elderly
  • Fragile population
  • Immunocompromised host
  • Hospital wide
  • Outpatient clinic
  • SARS-CoV-2
  • Acute SARS-CoV-2
  • Pharmacological intervention
  • Monoclonal antibodies
  • Sotrovimab
  • Tixagevimab/Cilgavimab
  • Casirivimab/Imdevimab

POSTCODE

United Kingdom
|
2021-2024
  • Adults
  • General population
  • Elderly
  • Paediatric
  • Hospital wide
  • Outpatient clinic
  • SARS-CoV-2
  • Post-COVID-19

Azevedo

Portugal
|
2021-2022
  • Adults
  • General population
  • Elderly
  • Hospital wide
  • Intensive care unit
  • SARS-CoV-2
  • Post-COVID-19

MEADOWSPRING

Argentina | Belgium |Brazil|Denmark|Germany|Mexico|Romania|Switzerland|Turkiye|Ukraine
|
2021-2022
  • Adults
  • Elderly
  • Paediatric
  • Hospital wide
  • Outpatient clinic
  • SARS-CoV-2
  • Post-COVID-19

Peghetti

Italy
|
2021-2023
  • Adults
  • General population
  • Elderly
  • SARS-CoV-2
  • Post-COVID-19
  • Non pharmacological intervention
  • Rehabilitation

BRAINSTORM

France
|
2021-2022
  • Adults
  • General population
  • Elderly
  • Hospital wide
  • SARS-CoV-2
  • Post-COVID-19

Lindsay

United Kingdom
|
2021
  • Adults
  • Fragile population
  • SARS-CoV-2
  • Post-COVID-19